You’ve seen the claims: “Clinically proven to reduce cortisol by 27%.” “The natural stress solution backed by science.”
Ashwagandha was the third most-purchased herbal supplement in the United States in 2024, generating $144 million in sales. The pitch is simple — it lowers cortisol, the “stress hormone,” so it reduces stress.
There’s just one problem. When researchers pool the data from multiple clinical trials, ashwagandha reliably lowers serum cortisol — but it does not reliably reduce how stressed people actually feel.
This is the ashwagandha cortisol paradox. And it reveals something important about how the supplement industry sells you lab values instead of outcomes.
The Evidence: What Ashwagandha Actually Does to Cortisol
Let’s start with what’s real. The cortisol reduction is genuine.
A 2024 systematic review and meta-analysis by Bonilla et al. in the Journal of Functional Foods pooled data from randomized controlled trials and found ashwagandha supplementation produced a statistically significant reduction in serum cortisol, with a standardized mean difference of approximately -0.45 to -0.58 compared to placebo. Multiple individual trials using KSM-66 extract at 600 mg/day have shown morning cortisol reductions of roughly 15–27% over 8–12 weeks.
A 2026 meta-analysis of 22 RCTs (1,391 adults) published in Complementary Therapies in Medicine confirmed significant effects on stress-related biomarkers, with effects strongest at doses ≤500 mg/day over treatment periods longer than 8 weeks.
So far, so good. The supplement does something measurable to a real biological marker. But here’s where it gets complicated.
The Paradox: Cortisol Goes Down, Felt Stress Stays the Same
When researchers looked at perceived stress — measured using validated instruments like the Perceived Stress Scale (PSS-10) or the Depression Anxiety Stress Scales (DASS-21) — the picture changes.
The Bonilla et al. meta-analysis found that when PSS scores were pooled across adequately powered trials, the reduction was non-significant, with confidence intervals crossing zero. A 2024 review examining RCT evidence quality found high heterogeneity in self-reported stress outcomes — some individual trials showed benefits, but the pooled signal disappeared when studies with high risk of bias were excluded.
Speers et al., writing in Current Neuropharmacology (2024), noted this cortisol-stress dissociation as a “key unresolved question” in ashwagandha research.
In plain English: ashwagandha consistently moves a number on a lab report. It inconsistently changes how people actually experience their daily lives.
Why Lowering Cortisol Doesn’t Equal Feeling Less Stressed
This paradox only seems strange if you accept the marketing premise that cortisol is “the stress hormone.” It isn’t. Cortisol is a metabolic regulator that does hundreds of things in your body — glucose metabolism, immune modulation, circadian rhythm regulation, anti-inflammatory signaling. Stress is just one of many signals that trigger cortisol release.
Here’s why the disconnect exists:
1. The HPA Axis Is Not the Same as Your Brain’s Stress Centers
Ashwagandha’s withanolides appear to act on the hypothalamic-pituitary-adrenal (HPA) axis — the hormonal cascade that regulates cortisol production. But the subjective experience of stress is generated in the prefrontal cortex, amygdala, and anterior cingulate cortex — brain regions that process threat appraisal, rumination, and emotional distress.
These systems interact, but they are not the same system. You can have low cortisol and high perceived stress (as seen in PTSD and Addison’s disease) or high cortisol and low perceived stress (as seen during intense exercise or exciting challenges).
Lowering cortisol pharmacologically is like lowering heart rate with a beta-blocker — it changes a physiological parameter without necessarily changing the psychological experience.
2. Single Cortisol Measurements Are Unreliable
Most ashwagandha trials measure morning fasting serum cortisol — a single snapshot at one moment. But cortisol is pulsatile and follows a diurnal curve. A single measurement is a poor proxy for total cortisol exposure or stress reactivity.
As Hellhammer et al. established in Psychoneuroendocrinology (2009), single cortisol measurements have poor reliability and are influenced by food intake, exercise, sleep quality, smoking, oral contraceptives, and time of day. A more meaningful measure — hair cortisol, which reflects months of cumulative exposure — is rarely used in ashwagandha research.
3. Chronic Stress Can Actually Flatten Cortisol
Here’s an uncomfortable finding for the “high cortisol = high stress” narrative: Miller, Chen, and Zhou’s landmark 2007 paper in Psychological Bulletin demonstrated that chronic stress can flatten the cortisol diurnal curve rather than elevate it. People under the most severe chronic stress may actually have lower baseline cortisol, not higher.
This means the entire framing — “you’re stressed, your cortisol is high, take this to lower it” — may be backwards for the people who need help most.
The Funding Problem Nobody Talks About
There’s another layer to this story. Of the approximately 15–20 published RCTs on ashwagandha and stress, roughly 70–80% were funded or product-supplied by extract manufacturers — primarily Ixoreal Biomed (maker of KSM-66) and Natreon Inc. (maker of Sensoril).
This matters because industry-funded supplement trials consistently show larger effect sizes than independent trials — a pattern documented across all supplement research (Lexchin et al., BMJ, 2003). When independent reviewers restrict their analysis to low-risk-of-bias studies, the effect sizes for subjective stress outcomes shrink dramatically.
The NIH’s National Center for Complementary and Integrative Health (NCCIH) reflects this reality: “Some preliminary research suggests ashwagandha might help reduce stress and anxiety, but the evidence is not strong enough to make definitive conclusions. Most studies have been small, short in duration, and have methodological limitations.”
Examine.com, one of the most rigorous independent supplement databases, rates the evidence for cortisol reduction as “Moderate” but the evidence for stress/anxiety reduction as “Low to Moderate.”
Safety: The Emerging Liver Concern
While most people tolerate ashwagandha well short-term, a safety signal has emerged that the supplement industry has been slow to acknowledge.
The Icelandic Medicines Agency and Swedish regulatory bodies have flagged multiple case reports of ashwagandha-associated hepatotoxicity — elevated liver enzymes, jaundice, and in at least two documented cases, acute liver failure requiring hospitalization.
Björnsson and Björnsson presented five Icelandic cases at the European Association for the Study of the Liver (EASL) in 2022, with a temporal pattern consistent with drug-induced liver injury (DILI). The NIH’s LiverTox database has since updated its ashwagandha entry, grading it as Category C: probable cause of clinically apparent liver injury, with onset typically 2–12 weeks after starting supplementation.
The European Food Safety Authority (EFSA) initiated a safety review of ashwagandha-containing supplements in 2024 following reports from multiple member states. Some Nordic countries have moved toward restricting sales or requiring warning labels.
Additionally, ashwagandha can increase thyroid hormone levels (T3 and T4), which is potentially dangerous for people with hyperthyroidism or those taking thyroid medication. Several case reports of thyrotoxicosis have been published.
This doesn’t mean ashwagandha is dangerous for most people. But it means the “it’s just an herb, it’s natural, it’s safe” framing is irresponsible — and the liver signal deserves monitoring, not dismissal.So What Should You Actually Do?
Here’s our honest assessment:
Ashwagandha may be worth trying if:
- You’re dealing with acute, identifiable stress (new job, exam period, life transition) rather than chronic, diffuse anxiety
- You’ve already addressed the foundations: sleep, exercise, social connection, and professional support if needed
- You use a standardized extract (KSM-66 or Sensoril) at 300–600 mg/day
- You treat it as an 8-week experiment with honest self-assessment, not a permanent fixture
- You have no liver conditions and are not taking thyroid medication
Ashwagandha is probably not the answer if:
- You’re looking for a pill to solve chronic burnout without changing the conditions causing it
- You’re drawn to it primarily because of cortisol marketing claims
- You’re already taking anxiolytics, SSRIs, or thyroid medication (interaction risks)
- You have any history of liver problems
What actually reduces perceived stress (strong evidence):
- Regular exercise — 150 min/week of moderate activity reduces perceived stress scores more reliably than any supplement in the literature
- Sleep optimization — 7–9 hours consistently; poor sleep elevates both cortisol AND perceived stress
- Cognitive behavioral techniques — Even self-guided CBT shows consistent stress reduction in meta-analyses
- Social connection — Loneliness is a stronger predictor of cortisol dysregulation than any supplement can counteract
The Bigger Lesson: Don’t Buy Lab Values
The ashwagandha cortisol paradox is a case study in how the supplement industry works. Find a compound that moves a biomarker. Equate that biomarker with a condition people care about. Sell the supplement as a solution to the condition.
It’s the same logical structure that created pharmaceutical controversies — drugs that lower LDL cholesterol without reducing heart attacks, drugs that improve bone density scores without reducing fractures. A surrogate endpoint is not a clinical outcome.
Your supplement may be treating a lab value, not your experience.That doesn’t make ashwagandha worthless. The cortisol reduction is real, and some individuals do report meaningful stress relief — possibly through GABA-A receptor modulation or other mechanisms beyond cortisol. But the honest framing is: the evidence is weaker and more complicated than the marketing suggests, the funding landscape creates bias, and the safety profile is less pristine than “it’s just an herb” implies.
We think you deserve to know that before you spend $30–60 a month on a supplement because an Instagram ad told you your cortisol was too high.
References
Join the HappierFit Community
Evidence-based insights on emotional fitness, physical health, and building a life that actually works. Free. No spam. Unsubscribe anytime.
We respect your inbox. Unsubscribe anytime.